PCN12 COST-EFFECTIVENESS OF PEMBROLIZUMAB COMPARED TO CHEMOTHERAPY AS A TREATMENT FOR PATIENTS WITH PREVIOUSLY TREATED ADVANCED MELANOMA IN CHINA
Abstract
Authors
W. Tang R. Aguiar-Ibáñez Y. Shen E. Scherrer R. Shao J. Wang A. Ma